期刊名称：DIABETES CARE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes. To achieve these goals, the journal publishes original articles on human studies in the following four categories: 1) clinical care/education/nutrition, 2) epidemiology/health services/psychosocial research, 3) emerging treatments and technologies, and 4) pathophysiology/complications. The journal also publishes clinically relevant review articles, letters to the editor, and health/medical news or points of view. Topics covered are of interest to clinically oriented physicians, researchers, epidemiologists, psychologists, diabetes educators, and other health professionals. |
Instructions to Authors
CONTENTS:
ABOUT THE JOURNAL
WEB-BASED MANUSCRIPT SUBMISSION
EDITORIAL OFFICE CONTACT INFORMATION
MANUSCRIPT TYPES
FORMS AND REQUIREMENTS
MANUSCRIPT STYLE AND FORMAT
SUBMITTING A MANUSCRIPT (PLEASE READ THIS)
MANUSCRIPT TYPES
Original articles report clinical investigations and findings, noteworthy individual case experiences, and technical developments in areas relevant to the care of patients with diabetes. [NOTE: Diabetes Care does not take papers regarding in-vitro work.]
Authors should limit articles to 5,000 words, allowing 500 words for each table or figure in the article. For example, an article with two figures and one table should contain no more than 3,500 words [5,000 - (3 x 500)]. All words should be counted except for tables, table legends, figure legends, and references. Include the title, author names, abstract, entire text, and acknowledgments in the word count. References are limited to three pages. Authors who cannot conform to this limit should provide specific reasons in their comments to the editor. Exceptions to the 5,000-word limit are rare.
Because of the increasing number of submissions and limited editorial space, as of December 2003, word count limits are being strictly enforced. Papers will be automatically declined if they are over the allowed word count unless accompanied by a letter stating why the authors found it necessary to exceed the limit (within reason).
The following features are essential: hypothesis testing, suitable controls, appropriate statistical methods, clear reporting of results, and conclusions supported by the results. Papers will be judged on their uniqueness and importance.
Where appropriate, clinical and epidemiological studies should be analyzed to see if there is an effect of sex or ethnicity. If there is no effect, is should be so stated in the results section.
Authors of reports of randomized controlled trials are required to use the instructions and checklist in the Consolidated Standards of Reporting Trials (CONSORT) Statement, these instructions and checklist are designed to ensure that information pertinent to the trial is included in the study report.
Brief reports are succinct case reports and observations relating to the practice of diabetology. A brief report should be formatted in one of two ways:
1. Clinical observations/research report style, which consists of a short introductory paragraph stating the study's objectives, followed by four concise sections: "research design and methods," "results," "conclusions," and "references."
2. Case report/case study style, which consists of a short introductory paragraph followed by four sections: "history and examination," describing the patient and giving a brief history; "investigation," discussing the treatment findings and results; "conclusions," summarizing the importance of the findings/results in one or two paragraphs; and "references."
Neither format should exceed 1,000 words, excluding the references. Each brief report may include either one table or one figure, but not both. Each manuscript must include a title page stating the title, the short running title, the authors' full names and degrees, the authors' affiliations, the contact information for the corresponding author, the word count, and whether a table or figure is included. (NOTE: Brief Reports are subject to peer review at the discretion of the Editor. Four to six Suggested Reviewers are requested for both Original Articles and Brief Reports.)
Diabetes Care publishes Commentaries on an occasional basis. Commentaries are brief articles presenting the authors' views on a topic of current clinical interest. In general, commentaries are invited by the editors.
Review articles are comprehensive, scientifically accurate summaries of topics in clinical or basic science dealing with areas of current clinical relevance, with promising experimental therapies, or with emerging scientific concepts. Reviews should describe basic and clinical investigations, discuss the physiological and clinical significance of the work, and place it in the context of previously published information. Contributors identify areas of agreement and disagreement among researchers, promote unifying hypotheses to explain current controversies, and explore potential avenues for further investigation. Authors also need to discuss what process is used in the review of the literature.
Review articles are taken by invitation or approved submission after query by author(s).
By invitation: Editorial staff will invite qualified person(s) to write a review article on a selected topic.
By author query: Before a review article (or a commentary) can be submitted for peer review and possible publication, a proposal and outline of the article must be submitted to, and approved by, the editor of Diabetes Care.
The proposal should include: 1) a detailed outline of the content of the proposed review; 2) a general idea of the amount of original literature to be summarized; and 3) the background of the author(s) supporting his/her expertise in the area to be discussed in the review (or commentary). It is anticipated that the author(s) will have worked and published in the area of the review or commentary. The author should also state why he/she feels this particular review is suited for Diabetes Care and why the review article would appeal to the readership.
In addition, the authors must disclose whether they propose to write the entire article themselves, whether they received any form of sponsorship or honorarium for the material, and whether a pharmaceutical company, or its representative, was involved in the funding or authorship. The authors must also point out any potential conflict of interest with a company whose products will be discussed in the review.
All proposals should be submitted by e-mail (with Word document attachments) to Lyn Reynolds in the Diabetes Care Editorial Office (Lreynolds@diabetes.org). The proposal will then be scheduled for discussion at the next meeting of the editor and associate editors.
An invitation to submit does not guarantee publication. Like original articles submitted to the journal, review articles (whether invited or by query) are subject to peer review.
Review articles submitted without prior approval or invitation will be returned.
Letters to the editor include opinions on topics published in the journal or related to diabetes in general. There are two sections of letters: Comments and Responses and Observations.
Comments and Responses: Although there is no set time limit on submitting a comment on a published article, authors should make certain that no other letter pertaining to the issue they wish to raise has been published in response to the same article. The article on which the letter comments should be included as reference 1 in the reference list. The Editor reserves the right to ask authors of the cited article to respond.
Letters do not have abstracts and should not exceed 500 words, including the references. The inclusion of tables or figures in letters is discouraged. As with all submissions, letters should be double-spaced and include a title page with the authors' full names, degrees, and affiliations and the corresponding author's contact information.
Observations: This type of letter includes brief reports and case reports. They should be formatted as above. (These letters may be slightly longer; however, authors are encouraged to adhere to word limit as closely as possible.)
Note: During the online submission process, please type "NONE" in the abstract box.
As with all submissions, authors of letters are required to furnish signed copyright transfer and duality of interest forms (and when necessary, duality disclosure statements). TOP
FORMS AND REQUIREMENTS
Diabetes Care publishes only material that has not been published previously (either in print or electronically) and is not under consideration for publication elsewhere, with the exception of an abstract that is less than 400 words in length. Prior publication of any of the data on the Web should be disclosed in the author's comments to the editor in chief upon manuscript submission.
The American Diabetes Association (ADA) holds the copyright on all material appearing in Diabetes Care. All authors must sign the copyright assignment form furnished in the journal, which transfers copyright to the ADA in accordance with the Copyright Revision Act of 1976.
All authors must read the ADA Policy Statement on Duality of Interest and complete the duality of interest disclosure statement, which can be found in every issue of Diabetes Care. Relevant duality or conflict of interest--or the lack thereof--should also be disclosed in the authors' comments to the editor during the submission process.
Authors submitting articles containing color figures must sign and return a Color Approval form. Forms will be faxed or e-mailed from the Editorial Office upon receipt of color figures. The cost of printing in color, to be borne by the author, is $630 U.S. per color figure. (NOTE: color fees are based on individual figures as a whole, not by the part, i.e., A, B, C, etc.) After submission of the form, authors will receive a pro forma invoice for publication fees when page proofs become available.
NOTE: You must fax (317/354-8379) or mail the completed copyright and duality forms to the editorial office at the time you submit your manuscript. Your submission will not be considered complete until these forms have been received. Please write your manuscript number, which is assigned once you have finished the submission process on the website, on all of your forms.
Diabetes Care subscribes to the requirements stated in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (N Engl J Med 336:309-315, 1997) that authorship implies substantial contributions to conception and design or analysis and interpretation of data and drafting of the article or critical revision for important intellectual content. The editor reserves the right to query authorship contribution. NOTE: As of 1 September 2003, Diabetes Care limits the number of authors to 8 from the same institution and 12 from multiple institutions.
All human investigation must be conducted according to the principles expressed in the Declaration of Helsinki. All studies involving animals must state that guidelines for the use and care of laboratory animals of the authors' institution or the National Research Council or any national law were followed.
TOP
MANUSCRIPT STYLE AND FORMAT
The manuscript should be arranged in the following order: title page, abstract, introduction (no heading), research design and methods, results, conclusions, acknowledgments, references, tables, and figure legends.
Title page
A Title Page must be included in all submissions as the first page of the text document (including letters and brief reports). Titles should be brief. Also include a short running title (less than 40 characters); first name, middle initial, last name, and the highest academic degree of each author; affiliation (in English) of each author during the study being reported; name, current address, telephone number, fax number, and e-mail address of corresponding author; and the word count and number of tables and figures.
Abstract
An structured abstract is required for all original articles. In addition to inserting the abstract in the abstract field, it should also be included in the text document, following the title page. The abstract should not exceed 250 words. It must be self-contained and clear without reference to the text and should be written for a general journal readership. The abstract must be in a structured format: Objective, purpose or hypothesis of study; Research Design and Methods, basic design, setting, number of participants and selection criteria, treatment or intervention, and methods of assessment; Results, significant data found; and Conclusions, validity and clinical applicability.
Text
Terminology and style. Articles should be written in clear, concise English following the recommendations for scientific writing found in Scientific Style and Format, the Council of Biology Editors (CBE) style manual (6th ed., 1994, Bethesda, MD, Council of Biology Editors). All accepted manuscripts will be edited according to the CBE style manual and The Chicago Manual of Style (14th ed., 1993, Chicago, IL, The University of Chicago Press) by ADA professional publications staff. The authors are responsible for all statements made in their articles or editorials, including any editing changes made by staff.
The designations type 1 diabetes and type 2 diabetes should be used when referring to the two major forms of diabetes. The term diabetic should not be used as a noun.
Abbreviations. Abbreviations should be used only when necessary, e.g., for long chemical names (HEPES), procedures (ELISA), or terms used throughout the article. See the list of abbreviations below for those that need not be defined; all others must be defined at first use. Abbreviate units of measure only when used with numbers. Abbreviations may be used in tables and figures. The CBE style manual contains lists of standard scientific abbreviations.
Units. Clinical laboratory values should be in Système International (SI) form (see SI table in each issue). Kilocalories should be used rather than kilojoules. Glycated hemoglobin should be expressed as percentage of total and as standard deviation from mean control levels.
Materials. Authors should provide the name and location of the source for specified chemicals and other materials only if alternate sources are considered unsatisfactory.
Acknowledgments
Acknowledgments should contain brief statements of assistance, financial support, and prior publication of the study in abstract form, if needed.
References
References should be listed according to the following examples and should be numbered in the order that they are cited in the text. All authors must be listed and inclusive page numbers provided. Journal titles should be abbreviated as in Index Medicus; for unlisted journals, complete journal titles should be provided. Unpublished material may not be cited. Material that is in press may be cited, but copies of such material may be requested. Authors are responsible for the accuracy of the references.
Journal articles:
Banting FG, Best C: The internal secretion of the pancreas. J Lab Clin Med 7:251-266, 1922
Abstracts:
Seaborn J: Gastrointestinal side-effects of high-fiber diets in diabetic rats (Abstract). Gut 33:A4304, 1992
Books:
Allen FM: Studies Concerning Glycosuria and Diabetes. Bradley RF, Krall LP, Eds. Cambridge, MA, Harvard Univ. Press, 1913
Chapters in books:
Stauffacher W, Renold AK: Pathophysiology of diabetes mellitus. In Joslin's Diabetes Mellitus. 11th ed. Marble A, White P, Bradley RF, Krall LP, Eds. Philadelphia, Lea & Febiger, 1971, p. 35-98
Government publications:
Fajans SS (Ed.): Diabetes Mellitus. Washington, DC, U.S. Govt. Printing Office, 1976 (DHEW publ. no. NIH 76-854)
Online publications:
Beta cell function in type 2 diabetes: glucose metabolism and insulin secretion in the normal pancreas [article online], 1999. Available from http://www.amaryl.com/TXT/Clinical_Management/Overview/beta_cell_failure_TXT.html. Accessed 4 May 2000
Tables
Tables should be double spaced on separate pages with table number and title. Tables with internal divisions (Tables 1A and B) should be submitted as individual tables, i.e., Tables 1 and 2. Symbols for units should be confined to column headings. Abbreviations should be kept to a minimum and defined in the table legend. For footnotes, use the following symbols consecutively, left to right, top to bottom of table: *, ? ? ? ||, #, **, ††.
Figures
In most instances, figures will be reduced to one-column width (about 2 1/4 inches) for publication and should be produced accordingly. Information on the axes should be succinct, using abbreviations where possible, and the label on the y-axis should read vertically, not horizontally. Key information should be placed in any available white space within the figure; if space is not available, the information should be placed in the legend. In general, figures with multiple parts should be marked A, B, C, etc., with a description of each panel being placed in the legend rather than on the figure.
Lines in graphs should be bold enough to be easily read after reduction, as should all symbols used in the figure. Data points are best marked with the following symbols, again assuring that they will be readily distinguishable after reduction:  . IMPORTANT NOTE: In the figure LEGEND, please use words rather than the symbols; e.g., "black circles = group 1; white squares = group 2; black bars = blood glucose; white bars = C-peptide." Bars should be black or white only, unless more than two datasets are being presented; further bars should be drawn with clear bold hatch marks or stripes, not shades of gray.
Line or bar graphs or flow charts with text should be created in black and white, not shades of gray, which are difficult to reproduce in even tones.
Color figures incur an additional charge, paid by the author; they should not be submitted for reproduction in black and white. The charge for each color figure published is $630.
If you submit figures in color but request to have them reproduced in black and white or submit charts or graphs with gray backgrounds or bars, you will be asked to send new figures and the publication of your paper may be delayed. If you choose not to submit new figures, the publisher cannot be held responsible for the print quality of the images.
If materials (e.g., figures and tables) are taken from other sources, the author must be able to provide written permission for reproduction obtained from the original publisher and author.
Editorial Board
Editor in Chief
Mayer B. Davidson, MD
Associate Editors
Andrew J.M. Boulton, MD, FRCP
William T. Cefalu, MD
Ann M. Coulston, MS, RD
Vivian Fonseca, MD
William Herman, MD, MPH
Eli Ipp, MD
Lois Jovanovic, MD
Harold E. Lebovitz, MD
Seymour R. Levin, MD
Mark F. Peyrot, PhD
Marian J. Rewers, MD, PhD
Richard R. Rubin, PhD
Ruth S. Weinstock, MD, PhD
Editorial Board
David G. Armstrong, DPM, MSc
Edward J. Boyko, MD, MPH
Edwin D. Bransome Jr., MD
Antonio Ceriello, MD
H. Peter Chase, MD
Emily V. Chew, MD
John N. Clore, MD
Daniel J. Cox, PhD, ABPP
William C. Duckworth, MD
Michael M. Engelgau, MD
Rejeanne D. Gougeon, PhD
Margaret Grey, DRPH, FAAN, CPNP
Michael A. Harris, PhD
Nicolas Katsilambros, MD
Ingrid Muhlhauser, MD
Anne T. Nettles, RN, MSN, BC-ADM
Jerry P. Palmer, MD
John D. Piette, PhD
Judith Gail Regensteiner, PhD
Burton E. Sobel, MD
Michael Tuck, MD
Aaron I. Vinik, MD
Lynne E. Wagenknecht, DRPH
Elizabeth Walker, DNSc, RN
Jean-Francois Yale, MD
EDITORIAL OFFICE CONTACT INFORMATION
Diabetes Care Editorial Office
6919 E. Tenth St.
Suite B-2
Indianapolis, IN 46219
phone: (703) 549-1500, ext. 1775
fax: (317) 354-8379
e-mail: DiabetesCare@diabetes.org
|
